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The transition from intra- to extra-uterine life is one of  the greatest physiological 
challenges that occur in the life of  animals. Immediately after birth, newborn calves 
have to adapt to new environmental and feeding conditions. Namely, at birth a break 
of  the thermal balance occurs, since calves abruptly pass from a 38.8°C temperature in 
utero to an environmental temperature that is generally lower than 20°C. Additionally, 
at birth, the energy intake shifts from a continuous parenteral supply of  nutrients 
(mainly glucose) to discontinuous colostrum and milk intake with lactose and fat as 
the main energy sources. Therefore, the most important issues related to metabolic 
changes during the transition from intra- to extra-uterine life are related to maintaining 
the homoeothermic conditions and control of  energy metabolism. Those metabolic 
adaptations are under control of  the endocrine system that is relatively mature at birth, 
but still requires morphological and functional changes after birth. Key hormones 
whose concentrations are signifi cantly changed around birth and are involved in an 
adequate adaptation of  calves to extra-uterine life are those related to stress at birth 
(cortisol and cathecholamines), glucoregulatory processes (insulin and glucagon), 
thermogenesis (thyroid hormones) and growth (IGF axis). 
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INTRODUCTION
The transition from fetus to newborn is the most challenging period in the life of  
animals, since great morphological and functional changes occur in order to prepare 
the organism for extra-uterine life. Those changes include the maturation of  the 
endocrine system, metabolic pathways, vital organs and immune system. It is not 
uncommon that these adaptation mechanisms fail and become risk factors for health 
disturbances. Therefore, morbidity and mortality rates in the perinatal period (period 
from day 270 of  pregnancy to 24 hours of  life) are the highest of  all life stages of  an 
animal [1,2]. Morbidity and mortality remain high during the neonatal period (from 
day 2 to day 28 of  life) and then decline as calves develop and gain in body weight [3]. 
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Raboisson and coworkers [4] presented that mortality of  dairy calves during the fi rst 
month of  life range up to 17%. Based on data presented by USDA for year 2007, 50% 
of  calf  mortality was directly related to inadequate passive immunity while 50% was 
related to non-immunological factors [5].
In order to effectively prevent losses related to health disturbances during the perinatal 
and neonatal periods of  life, it is important to understand the conditions and factors 
for success and failure of  adaptation mechanisms. In general, the factors infl uencing 
newborn calf  morbidity and mortality may be divided between immunological and 
non-immunological factors. There are numerous reviews [6-10] that deal with factors 
that affect the maturation of  the immune status of  neonatal calves (immunological 
factors), since those factors are considered to be essential for the survival of  the 
neonate. Namely, calves are born agammaglobulinemic and have to achive full maturity 
of  immunity during early neonatal life [10]. On the other hand, there are only few 
reviews that describe non-immunological factors [11-12] that contribute to an adequate 
adaptation of  newborn calves, but are not defi ned as life-threatening. Therefore, with 
no aim to diminish the importance of  the immune system development for offspring 
survival, this review will emphasise the role of  endocrine and metabolic factors for 
adequate adaptation of  calves to extra-uterine life, since those factors signifi cantlly 
contribute to an orchestrated physiological adaptation of  newborns.  
ENDOCRINE CHANGES
The endocrine status of  the fetus is essential for maturation of  fetal organs that have 
to be fully prepared for the cessation of  direct maternal supply with oxygen and 
nutrients which occurs during birth. Nevertheless, many organs are still immature at 
birth and need further maturation during the early neonatal period. Coincidentally, the 
hormonal status of  fetal and newborn calves is not fully developed and is exposed 
to dramatic changes during late gestation and the early neonatal period in order to 
provide an adequate adaptation of  newborns to the extra-uterine environment.
Key hormones that are involved in the adequate adaptation of  calves to extra-uterine 
environment are cortisol, cathecholamines, insulin, glucagon, thyroid hormones and 
insulin like growth factors-I and -II [IGF-I and -II). Cortisol and cathecholamines 
secretion is associated with birth related stress [13-15], while insulin and glucagon 
secretion contributes to the regulation of  glucose and energy metabolism [16]. Thyroid 
hormones are mainly involved in thermogenesis of  neonete [17]. IGF-I and –II, that 
are a part of  the IGF system, are essential for growth and development of  different 
fetal and neonatal organs [18]. 
Cortisol 
Cortisol, a hormone known to be involved in the stress response, is the factor that 
prepares the fetus for birth, but also supports the maturation of  many organs and 
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metabolic pathways during the transitional period from intra-uterine to extra-uterine 
life [13].  
Most of  the fetal cortisol is synthesized in fetal adrenal glands, since very little transfer 
of  cortisol between maternal and fetal compartments seems to occur [14]. The fetus is 
also protected from the high maternal cortisol by the presence of  11β-hydroxysteroid 
dehydrogenase type 1 (11β-HSD1), a placental enzyme which oxidizes cortisol to 
the biologically inactive cortisone [19]. Placental 11β-HSD1 receptors are regulated 
by estrogen and the late-gestational rise in estrogen is associated with increased 
11β-HSD1-enzyme expression [20]. The increase in weight of  the fetal adrenal glands, 
as a consequence of  maturation of  the fetal hypothalamic-pituitary-adrenal axis, occurs 
mainly during the last month of  gestation [14] leading to elevated concentrations of  
fetal cortisol. The increased fetal cortisol concentration, that is at its highest during the 
last 3 to 5 days of  gestation, leads to the cascade of  endocrine events that provokes 
parturition, but also to essential maturation of  the fetal lungs and gastrointestinal 
tract in their preparation for extra-uterine life [21]. Additionally, the prenatal increase 
in cortisol concentration has a strong infl uence on maturation of  glucose metabolic 
pathways in the fetal liver [14]. Cortisol increases the incorporation of  glucose into 
glycogen in fetal hepatocytes, by induction of  glycogen synthetase. This effect can be 
augmented by subsequent administration of  insulin, although insulin administration 
with no additional cortisol does not result in glycogen accumulation in fetal hepatocytes 
[22]. 
After birth, before colostrum intake, the cortisol levels continuously rise and peak 
soon after delivery (“cortisol surge”) as a consequence of  birth-related stress. Cortisol 
level at birth is signifi cantly higher than in adult animals [23]. Colostrum provides 
additional cortisol to the neonate since maternal cortisol taken up by the mammary 
gland during colostrogenesis may be transferred to the neonate. Nevertheless, 60% of  
the cortisol in the colostrum is protein bound [24] and therefore not available for the 
neonate. With no additional source of  colostral cortisol and with absence of  stress, 
cortisol level signifi cantly decreases during the fi rst 12 hours of  neonatal life [23].
Cortisol concentration in newborn calves has a a strong impact on the adequate 
adaptation of  the animal to extra-uterine life. Cortisol enhances the maturation of  
some components of  the endocrine system since elevated cortisol level support 
catecholamine release by the adrenal tissues and maturation of  the thyroid axis leading 
to increased conversion of  T4 to T3.  The “cortisol surge” also increases β-adrenergic 
receptor density in many tissues including the heart and the lungs, and provoke, in 
association with thyroid hormones, maturation of  the surfactant system in the lung 
[25]. Glucocorticoids enchance the maturation of  the somatotropic axis around birth. 
Namely, the increased cortisol concentration during the perinatal period of  life plays 
an important role in initiating the prenatal switch of  the somatotropic axis from the 
fetal (when growth is indipendent of  growth hormone) to the postanatal status and 
function [26]. Literature data indicate that in farm animal species cortisol stimulates 
the development of  immature enterocytes, and causes enhanced immunoglobulin 
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absorption [9]. Glucocorticoids are essential in the maturation of  metabolic pathways 
involved in glucose metabolism in the neonatal liver [14]. It has been shown that 
increased cortisol levels in the newborn, like in the fetus, have major implications 
on glucose availability [27]. As shown by Girard [28], adrenalectomy in newborn rats 
inhibits glycogen breakdown by 15-20%, meaning that cortisol has a permissive role 
in glycogenolisis in newborns. Glucocorticoids are also essential for thermogenesis, 
and a marked increase in glucocorticoid concentrations has been reported in response 
to exposure to cold in neonatal calves [29]. It is most likely that glucocorticoides play 
an indirect role in supporting cold thermogeneisis through mobilization of  lipids and 
glycogen to supply energy thermogenesis [30].  
Based on data related to the impact of  birth-related increased levels of  cortisol on 
neonatal survival, it may be concluded that elevated physiological concentrations 
of  cortisol for a short period of  time (acute stress) are benifi cial for the long-term 
health of  a newborn. However, prolonged or repetitive exposure to elevated cortisol 
concentrations (chronic stress) can negatively affect the performance of  an animal 
[25]. 
Cathecholamines 
Catecholamines are present in the fetal plasma and they are released from the adrenal 
medullar tissues into the fetal circulation in response to fetal stressors, like hypoxia and 
asphyxia [31]. Fetal catecholamines suppress insulin secretion and may be responsible 
for the rise in plasma glucagon. Therefore, in severe hypoxia the fetus survives at 
the expense of  its glycogen reserves and the effects of  catecholamines in promoting 
glycogen breakdown are augmented by depression of  plasma insulin and rise of  
plasma glucagon [32]. Under physiological conditions, the fetus is partly protected 
from the metabolic effects of  stress mediated catecholamine release because the 
placenta increases catecholamine clearance [33]. 
At delivery, transient hypoxia initiates the additional secretion of  cathecholamines. 
Although plasma catecholamine concentrations are very high at delivery a rapid 
decrease during the fi rst 30 minutes of  postnatal life is found, followed by a signifi cant 
increase in their concentrations at the second postnatal hour, which coincides with the 
highest cAMP concentrations observed in the liver and with the onset of  signifi cant 
liver glycogen mobilization [34, 35]. The occurrence of  postnatal hypoglycemia could 
stimulate the increase in plasma catecholamine concentrations in the second postnatal 
hour. Nevertheless, it can be argued why the high plasma catecholamine concentration 
observed at birth is unable to promote liver glycogenolysis until then. It is tempting to 
speculate that high insulin concentrations observed at delivery could antagonize the 
catecholamine effects on liver glycogenolysis [36].
The postnatal catecholamine surge is, therefore, primarily responsible for the adaption 
of  energy metabolism with support of  the primary substrates for metabolism after 
birth – glucose and fatty acids, but is also responsible for other adaptive mechanisms 
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of  the newborns, like for the increase in blood pressure following birth, and for 
initiating thermogenesis from brown fat. Newborns are normally exposed to very high 
levels of  multiple vasoactive substances (catecholamines, angiotensin II and renin) 
that provoke increased blood pressure [37]. As far as infl uence of  catecholamines 
on thermogenesis, both adrenalin and noradrenaline stimulate brown adipose tissue 
(BAT) thermogenesis by the activation of  adenylate cyclase through binding of  
β-adrenergic receptors [38]. This binding leads to an increased activity of  cAMP which 
stimulates hormone-sensitive lipase which in turn activates lipolysis to provide fatty 
acids for mitochondrial respiration. Free fatty acids also have been shown to stimulate 
uncupling protein (UCP) activity that allows energy generated by mitochondrial 
respiration in BAT to produce heat.  Through binding of  both α and β adrenergic 
receptors, catecholamines also stimulate the synthesis of  iodothyronine 5`-deiodinase, 
leading to an increase of  endogenous production of  T3 hormone that plays an 
important role in enhancing the synthesis of  UCP. In addition to their role in BAT 
thermogenesis, catecholamines are involved in long term modulation of  BAT growth 
and development during cold stress. Therefore, catecholamines play critical roles both 
in the activation of  BAT thermogenesis during acute periods of  cold exposure and in 
the recruitment and proliferation of  BAT during sustained periods of  cold exposure 
[38]. 
Insulin and glucagon 
Insulin and glucagon are major hormones included in glucose homeostasis. In the fetal 
pancreas, functional maturation of  glucagon and insulin secreting cells is essential for 
optimal growth, development and metabolism of  the fetus, but also for an adequate 
adjustment of  the neonate to extra-uterine life. It may be assumed that the need for 
those glucose homeostatic mechanisms may be less during fetal compared to postnatal 
life because the fetus is partly protected by maternal homeostatic mechanisms. 
However, it is not the case especially in situations of  severe maternal malnutrition 
[39,40].   
Insulin secreting B cells and glucagon secreting A cells of  the pancreatic islets develop 
relatively early in gestation and can be detected in the islets of  fetal lambs at 40 to 50 
days of  pregnancy. Since there is no evidence of  placental fl ux of  either hormone, it 
can be concluded that both hormones originated from the fetal pancreatic cells [41,42].
Insulin plays a signifi cant role in regulating fetal glucose metabolism and the main 
determinant of  insulin secretion is changes in the fetal plasma glucose concentration 
[41]. Insulin stimulates glucose metabolism within insulin sensitive tissues or 
incorporates glucose into glycogen in the fetal liver. As previously mentioned, the 
latter action of  insulin is supported by cortisol [22]. Fetal insulin has also important 
effects on fetal amino acid metabolism which link fetal insulin status with fetal growth. 
Increased fetal glucagon concentrations coordinate with fetal hepatic glycogenolysis 
leading to a signifi cant increase of  plasma glucose concentrations, although no direct 
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effect of  glucagon on glycogenolysis was established in the fetal liver. Since Alexander 
and coworkers [42] have reported that glucagon concentrations in the fetal lamb are 
not infl uenced either by hyperglycemia or by hypoglycemia, it seems that during fasting 
diminished insulin concentrations will lead to a fall in the plasma insulin/glucagon ratio 
and increased dominance of  hepatic metabolism by glucagon. Since no signifi cant 
gluconeogenic activity is present before birth, it seems that glucagon contributes to the 
fetal glucose regulation exclusively through mobilization of  glycogen [42]. 
Therefore, both fetal insulin and glucagon participate in the regulation of  fetal 
metabolism during the last third of  gestation, the period when the biggest part of  fetal 
growth occurs and the  maternal nutritional status has its greatest effects on weight at 
birth [39].
At birth, plasma insulin concentrations are very high, decreasing rapidly afterwards 
and reach the low level plateau between 1 and 2 hours [43], while glucagon levels 
rise sharply, as a consequence of  adrenergic stimulation during birth-related stress, to 
peak at 30 minutes after birth. This leads to a big reduction of  the insulin/glucagon 
molar ratio and favors catabolic processes that lead to glycogen mobilization, starting 
at the second postnatal hour [34, 35]. As previously mentioned glycogen mobilization 
is provoked mainly by catecholamine increase supported by a decreased insulin/
glucagon molar ratio. There is a lot of  evidence that proves that glucagon by itself  is 
ineffective in triggering neonatal liver glycogenolisys [44, 45]. The partial resistance to 
glucagon stimulation by neonatal (and also fetal) hepatocytes could be due to (a) the 
lower number of  high affi nity receptors, or (b) an impaired coupling of  the receptor 
with adenilate cyclase [46]. The essential role of  glucagon postnatal rise is stimulation 
of  gluconeogenesis. Glucagon stimulates the transport of  pyruvate into mitochondria, 
which occurs during the fi rst hour after birth, activates the components of  the 
electron transport chain and so stimulates the phosphorylation of  adenine nucleotide, 
and induces the appearance of  PEP-carboxykinase – the rate limiting enzyme for 
gluconeogenesis [47].       
During suckling, colostral intake leads to the postprandial release of  insulin from 
neonatal pancreatic cells. Since insulin secretion mechanism is not fully matured, there 
are some speculations that partly absorbed colostral insulin may cover this insuffi ciency 
in secretion. Although neonatal gut capacity for insulin absorption is proved [43], it 
seems that colostral insulin, that is bound to milk casein [24], is not accessible for 
absorption [48]. The insulin axis in the neonate fully matures at day 7 of  life in calves 
[48], but insulin responses to nutrients in the newborn strongly depend not only on 
colostrum intake but also on maternal nutrition during pregnancy that may affect it. 
Nevertheless, it has to be emphasised that insulin response in cattle may be breed 
related [49]. Plasma glucagon concentrations also rise during the fi rst week after birth 
and provoke gluconeogenesis [48]. 
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Thyroid hormones  
The thyroid axis matures in late gestation parallel to the increase in cortisol level. This 
maturation includes increased thyroid stimulating hormone (TSH), T3 and T4 levels, 
and   decreased reverse triodothironine (rT3) levels as birth approaches [50]. The thyroid 
function prior to birth strongly interferes with cardiovascular and lung adaptation, as 
well as with thermogenesis in the newborn lamb [51].  At birth T3 and T4 levels are 
high [23, 43] and increase during the fi rst hours of  life due to both cortisol surge which 
supports  the maturation of  the thyroid axis and increased TSH secretion [52]. This 
peak in thyroid hormone concentration at birth considerably increases heat production 
and regulates cold thermogenesis. Nevertheless, acute changes of  thyroid hormone 
concentrations at birth have a minor infl uence on adaptation to extra-uterine life, 
when compared with the impact of  fetal thyroid axis maturation on postnatal adaptive 
mechanisms. After an initial increase, T4 and T3 concentrations rapidly decrease [23, 
43]. Results related to the infl uence of  suckling on thyroid hormone concentrations 
are inconsistent since some researchers confi rmed no infl uence of  feeding different 
amounts of  colostrum, delayed colostral intake, and fasting on thyroid hormone 
concentrations in the neonate [23, 43], while others demonstrated the correlation 
between the nutritional and thyroid status in neonates [53]. 
IGF system
The IGF system includes insulin-like growth factors I and II (IGF-I, IGF-II), their 
receptors (type 1 and type 2), and high affi nity binding proteins (IGFBPs). Six IGFBPs 
(IGFBP 1-6) bind blood IGFs, and the IGFBPs may alter the biological effects of  
IGFs action (I and II) [54]. IGFBP-3 increases the half-life of  IGF-I in the blood, 
while enchased IGFBP-1 and IGFBP-2 enables IGF-I to pass though the capillary 
walls into the extracellular space where it affects glucose metabolism. In conditions of  
balanced energy status, IGFBP-3 is the dominant IGFBP in the blood. In a state of  
energy restriction, blood concentrations of  IGFBP-1 are increased. There are some 
indications that IGFBP-2 concentrations are positively related to stress, although 
decreased IGFBP-2 levels in the blood may indicate on a decreased synthetic capacity 
of  hepatocytes [55].  
The IGF system regulates growth, both on systematic and tissue level, as well as 
metabolic adaptations of  calves during all stages of  fetal and neonatal development 
[56, 18]. Besides IGF system, growth hormone (GH) and insulin are responsible for 
growth of  fetal and neonatal calves, and their interrelation is signifi cantly changed 
during the transition from intra-uterine to extra-uterine life [57, 11]. There is a high 
similarity between the metabolic effects of  insulin and IGF-I, due to their cross-
reaction on the receptor level [58]. 
Fetal IGF-I  and –II are synthetised in many fetal tissues including the liver, kidney, 
lung, heart and adipose tissue [59]. Fetal growth is mainly under IGF-II and insulin 
control. IGF-I concentrations are 10 fold lower in the fetus than in adult animals [60]. 
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Syntehsis of  fetal IGF-I is indirectly infl uenced by glucose concentration, due to the 
fact that increased glycemia stimulates insulin secretion that enhances IGF-I synthesis 
[61]. Fetal IGF-I synthesis is not under control of  GH, as it is in the adult animal [57]. 
GH may be detected in ovine fetal circulation as early as day 130 of  gestation, but its 
origin is still unknown since there is no precise evidence that fetal adenohypophysis 
may synthetise GH [62]. Abundance of  IGFBPs in the fetal circulation differs from 
adult animals. In the human fetal serum, concentrations of  IGFBP-1 and IGFBP-2 
are twice higher and IGFBP-3 is three times lower than in adult animals [63]. 
In newborn calves, IGF system is basically functional, although it does not reach 
full maturity at that period. Neonatal calves are able to produce IGF-I mainly in the 
liver, but also in the gastrointestinal tract, spleen, thymus, lymph nodes, and kidney 
[64]. Effect of  GH on IGF synthesis seems to be smaller in neonatal calves than 
in older cattle. This may be a consequence of  the low GH binding capacity of  the 
neonatal liver [65]. Therefore, it may be speculted that some other factors contribute 
to changes in the serum IGF-I concentration. In the condition of  negative energy 
balance, that occurs immediately after birth, the concentration of  IGF-I depends on 
the concentration of  insulin in the circulation [66, 67]. There is a signifi cant positive 
correlation between IGF-I and insulin concentrations during the fi rst 2 hours of  
calf`s postnatal life, meaning that insulinemia, rather than GH, at birth affects IGF-I 
concentration [68]. In the condition of  additional energy supply by glucose infusion, 
IGF-I concentration is strongly positively infl uenced by glucose concentration [43]. 
IGF system in the neonate is also infl uenced by thyroid hormones partly due to the 
infl uence of  thyroid hormones on energy balance (metabolic rate) [69].
Kirovski and coworkers [68] showed that immediately after birth in neonatal calves the 
concentration of  IGFBP-3 is highest and concentrations of  IGFBP-2 and IGFBP-1 
are lowest. This IGFBP status is opposite than in most other animals and humans [70, 
71]. Thereafter, during the fi rst 90 minutes of  neonatal life, when calves are exposed to 
starvation, IGFBP-3 and IGFBP-2 concentrations signifi cantly decrease and IGFBP-1 
concentration signifi cantly increases [68]. Decreased IGFBP-3/IGFBP-1 ratio enables 
IGF-I to pass though the capillary walls into the extracellular space where it may 
complement effects of  insulin on glucose metabolism [72]. Murphy [73] showed 
that glucose concentration after birth has a strong infl uence on IGFBP ratio in the 
blood. In the study presented by Collett-Solberg and Cohen [74], hypoglycemia with 
hyperinsulinemia was coupled with a decrease of  IGFBP-3 concentration and increased 
IGFBP-1 concentration. The positive relationship between insulin and IGFBP-1 is in 
accordance with the well-known acute effect of  insulin on IGFBP-1 synthesis [75]. In 
a study presented by Kirovski and coworkers [43] hyperglycemia induced by glucose 
application immediately after birth provoked an increase of  IGFBP-3, with no effect 
on IGFBP-1 and IGFBP-2 concentrations, leading to a retention of  IGF-I in the 
circulation. Some authors observed a higher abundance of  IGFBP-2 in neonatal 
calves immediately after birth [43, 68, 76] and explained it by a stress reaction that is 
characterized by an increased concentration of  IGFBP-2 [77].
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It is well known that bovine colostrum is a signifi cant source of  immunoglobulines 
and that the concentration of  IgG in the colostrum is considered to be the hallmark 
for evaluating colostrum quality [78, 79]. Anyway, colostrum contains many other 
non-nutrient biologically active substances, such as hormones and growth factors, that 
are not essential for survival of  the neonate but have great impact on good health of  
offspring [18]. This is the case not only in bovine, but also in other domestic animal 
species [80]. Therefore, any disturbances in milk quality of  dams [81, 82] may affect 
the survival of  young animals. 
In contrast to other species where EGF is the dominant growth factor in the colostrum, 
IGF-I is the most abundant growth factor in bovine colostrum [83] and IGFBP-3 
is the major IGFBP in mammary secretion. Colostral IGF-I is not absorbed in 
signifi cant amounts [84, 85], probably due to interactions with colostral IGFBPs [85]. 
Because of  low rate of  absorption, colostral IGF-I ingestion has a minor infl uence 
on overall systemic growth and development, but has a strong impact on the neonatal 
digestive tract development. It reduces intestinal enzyme activity in the early postnatal 
period when calves are fed colostrum [86]. Although colostral IGF-I does not affect 
systemic IGF-I levels in a signifi cant manner, colostrum intake increases IGF-I plasma 
concentrations and hepatic IGF-I expression in neonatal calves [64, 87]. Therefore, 
plasma IGF-I concentrations are higher in neonatal calves fed colostrum than in cows 
fed mature milk, glucose or water [88]. Egli and Blum [89] showed that plasma IGF-I 
in suckling calves increases from day 1 to day 7 of  life. Therefore, in contrast to IGF-II 
[90], the IGF-I status can be in neonatal calves markedly modifi ed by feeding. 
METABOLIC ADAPTATIONS
During the transition from intra-uterine to extra-uterine life tremendous metabolic 
changes occur [91]. Those changes are strongly related to the hormonal pattern as 
well as to the developing rate of  mechanisms involved in metabolic pathways of  
certain metabolites. As the previous part of  this review described hormonal patterns 
of  neonates, the maturation of  components included in metabolic pathways will be 
presented in this section. A thermogenic response of  the neonate, strongly associated 
with the metabolic capacity of  neonates, will be presented as a separat section due 
to its great importance for neonatal survival. Most important issues related to the 
metabolic challenges during the perinatal period are related to carbohydrates i.e. 
energy metabolism and brown fat tissue metabolism that is strongly associated to 
thermal regulation. 
Carbohydrate metabolism and energy homeostasis 
During the life of  the fetus, the calf  relies on the supply with carbohydrates derived 
from the maternal circulation via the placenta. Carbohydrates are considered to be 
the most important source of  energy in the fetus. Glucose is the major carbohydrate 
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in the fetal blood of  many species but in ruminants fructose predominates. Namely, 
it has been shown that glucose, during its transfer from mother to fetus through 
the placenta, is partly converted into fructose which appears in the fetal blood [92]. 
Fructose is accumulated in the fetus since fructose, unlike glucose, cannot pass back 
into maternal circulation. Fetal blood fructose, that is highest in early pregnancy, tends 
to fall with increasing gestational age. Anyway, fetal fructose does not act as a reserve 
of  carbohydrate in the fetus since the enzymes necessary for its utilization are absent 
in the fetal liver [93]. It is supposed that the osmotic pressure of  fructose provokes the 
fl ow of  water into the fetus. 
The blood glucose concentration in fetal sheep is approximately 50% of   maternal 
blood glucose concentrations. The glucose uptake by fetal lamb is a result of  oxygen 
consumption and energy requirements [94]. Glucose is also required for the synthesis 
of  fructose, glycogen and fat in the fetus [95]. The level of  glycogen in fetal sheep liver 
is low very early in gestation, but it rises substantially in the last half  of  gestation up to 
parturition, when it reaches about double values compared to adults. Glycogen is also 
stored in skeletal muscles (fi ve times adult concentrations) and to a lesser extend in 
the lung and heart. Placental stores are low. This deposition of  glycogen is associated 
with a high activity of  enzymes required for synthesis of  glycogen from glucose 
[96]. Deposition of  glycogen in the fetus is associated with functional integrity of  
adrenal glands [97] and, as mentioned earlier, this effect can be augmented by insulin 
[22]. Elevated hepatic glycogen storage in the fetus, caused by an increased cortisol 
concentration in the fi nal stage of  gestation, enables the neonate to provide glucose 
immediately after birth. 
Glycogen stored in the fetus can be mobilized in time of  stress. It was shown that in the 
case of  undernutrition during late pregnancy in the sheep, fetal hepatic glycogenolysis 
may be stimulated, since the necessary enzymes and glucagon receptors are present 
in the liver of  the fetal lamb [98]. All the enzymes necessary for gluconeogenesis are 
also present in the fetal lamb liver during this period, but studies on the incorporation 
of  lactate into glucose suggest that no signifi cant gluconeogenic activity is present 
before birth [99]. Thus it seems that mobilization of  glycogen is a key mechanism 
that contributes to the short-term fetal glucose regulation. On the other hand, 
gluconeogenesis, regulated by glucagon, does not play a signifi cant part in fetal glucose 
homeostasis, although such a mechanism would be possible due to the large increase 
in amino acid catabolism observed during prolonged fasting [100].
At birth the placental supply of  carbohydrates from the mother stops abruptly and 
neonatal calves show hypoglycemia immediately after birth [68]. Because of  that, 
during the fi rst several hours of  life, meaning until fi rst colostrum intake, the newborn 
has to derive carbohydrates from its own endogenous sources through activation 
of  gluconeogenesis and glycogenolysis. Several studies showed that plasma glucose 
concentrations increased immediately after birth, without nutrient intake [68, 101]. 
The rise of  glucose concentration in the blood is a result of  postnatal glycogenolysis 
that is associated with an increase in sympathetic efferent activity [102]. Sympathetic 
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activity at birth also increases by as much as six fold, and the plasma free fatty acid 
concentration in the lamb rises within 2 h of  birth [103]. 
After parturition, liver glycogen level in the newborn ruminant falls rapidly to about 
10% of  fetal values within 2-3 h of  birth [104]. Liver gluconeogenesis increases soon 
after birth due to the induction of  phosphoenolpyruvate carboxykinase (PEPCK) 
activity, which is the key enzyme of  gluconeogeneis [105]. The maturation of  
gluconeogenic metabolic pathways is necessary for the supply with glucose during the 
starvation period. The cortisol surge that occurs immediately after delivery regulates 
the maturation of  gluconeogenic metabolic pathways [104]. Furthermore, the 
glucagon to insulin ratio in the blood plasma is one of  the factors that may contribute 
to gluconeogenesis and glycogenolisis immediately after birth [12]. Regarding to 
fructose concentration in the blood of  neonatal calves, it declines rapidly to very low 
values within 24 to 48 h of  birth. This is not the result of  metabolism of  fructose but 
rather of  excretion by means of  urine. The enzymes necessary to metabolize fructose 
do not appear in the liver until the 5th day post partum at which no fructose remains 
in blood [106]. 
During the suckling period the young animal is again depended on its mother for 
carbohydrates, supplied this time in the form of  milk lactose which must be hydrolyzed 
in the gut before it is absorbed from the small intestine. Enzymes that catabolise 
glucose and convert it to glycogen are present in the liver. Thus, liver glycogen, after an 
initial postnatal fall, rise to adult values 2 to 3 weeks post partum [104]. The maturation 
of  gluconeogenic metabolic pathways is essential during the colostral period, because 
lactose intake is not suffi cient to meet glucose demands in the neonate. 
Glucose requirements are completed by an active gluconeogenesis process during the 
suckling period, in which the main gluconeogenesis substrates are lactate, glycerol and 
the gluconeogenic aminoacids [107]. It was shown that activities of  enzymes involved 
in gluconeogenesis change markedly during the fi rst week of  life and are affected by 
feeding [108]. Colostrum feeding stimulates gluconeogenesis in the hepatocytes of  
newborn piglets [109]. 
Also, colostrum feeding impacts the glucagon to insulin ratio in the blood plasma 
[110]. Therefore, postnatal maturation, endocrine changes, and feeding may act in 
concert to stimulate metabolic processes in neonatal calves in accordance with their 
needs. Recently was shown [101] that endogenous glucose production, as well as 
gluconeogenesis, is not inhibited by insulin during euglicemic-hypergilcemic clamping, 
indicating a marked hepatic insulin resistance. Authors concluded that glucose 
production in the liver is not primarily regulated by endocrine factors, but probably by 
substrate availability or glucose disposal during neonatal period.
Besides lactose, colostrum supplies the neonate with fat, since colostrum, as a high-
fat diet, provides the bulk of  energy required for the hepatic oxidation of  fatty acids 
[111]. The induction of  this pathway occurs because of  an increase in the activities 
of  enzymes involved in the mitochondrial oxidation of  fatty acids. These enzymes are 
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maintained at high levels of  activity until weaning when a change of  diet occurs. Once 
suckling is established, the oxidation of  fatty acids results in an increase in plasma 
concentrations of  ketone bodies, which are the energy substrate for extrahepatic 
tissues during this period [112]. 
It is interesting to emphases that in the fetal and neonatal ruminant glucose can also be 
converted into fat, contrary to adult animal whose activity of  ATP citrate lyase, which 
is the key enzyme in the conversion of  glucose to fat, is low [113]. 
Brown adipose tissue metabolism and thermogenesis 
During the intra-uterine life of  the calf, metabolic heat has to be expended in order not 
to increase the body temperature of  fetus. At birth a break of  the thermal balance of  
the calf  occurs, since the calf  abruptly passes from a 38.8°C in utero to an environmental 
temperature that is generally lower than 20°C [114]. Heat loss of  the wet calf  is directly 
proportional to the difference between the skin and environmental temperatures. So, 
the new-born calf  has immediately to initiate thermolysis in physiological conditions 
that are not favorable due to hypoxia that occurs during parturition. This is the main 
reasons why hypothermia often takes place and may cause death of  weaker calves 
[115]. 
In order to maintain the thermal balance, the newborn calf  must adapt to extrauterine 
life by generating large quantities of  heat. Heat production of  newborn animals is a 
consequence of  metabolic processes in body tissues, the metabolism of  brown adipose 
tissue, shivering during physical activity and heat increment of  feeding [116, 117]. 
The nutrient reserves accumulated in the body that affect the metabolic rate of  body 
tissues are hepatic and muscular glycogen, labile proteins and lipids. Glycogen stores 
are rapidly mobilized and broken down in the starved calf  [102]. Glucose is used for 
thermogenesis and for physical activity. Protein mobilization also occurs probably due 
to the high levels of  cortisol after birth [23]. Body lipids are mobilized, as shown by 
the increase in plasma non esterifi ed fatty acids (NEFA) [118]. 
Two types of  adipose tissues exist in neonatal ruminants – white adipose tissue 
(WAT) and brown adipose tissue (BAT) [119]. BAT differs from WAT based on color 
and  multilocular distribution of  lipids within the cell. The color of  BAT is from 
light tan to reddish brown, partly because of  a lower lipid concentration and greater 
concentration of  mitochondria and blood vessels than in WAT. As well known, the 
primary function of  WAT is storage and release of  fatty acids for use as energy source, 
and, the primary function of  BAT is to generate heat by non-shivering thermogenesis 
meaning without electrical activity that occurs in the skeletal muscle that produce heat 
by shivering [120]. The capability of  BAT thermogenesis is attributed to a unique 32 
000 Mr uncupling protein (UCP) located in the inner mitochondrial membrane [121]. 
The UCP in BAT mitochondria allows mitochondrial respiration to be uncoupled 
from oxidative phosphorylation (synthesis of  adenosine triphosphate-ATP) thereby 
using the energy generated by mitochondrial respiration in BAT to produce heat rather 
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than ATP [121]. On the contrary, in the mitochondria of  skeletal muscles where UCP 
is not present, mitochondrial respiration is coupled with oxidative phosphorylation 
and production of  ATP. Heat is produced in muscle tissue only when ATP is used 
(i.e. muscle contraction) [115]. Similar to shivering muscle tissue, the ability of  BAT 
to generate heat depends on the rate of  substrate (i.e. fatty acids, glucose) oxidation 
in the mitochondria. During the initial phase of  thermogenesis the fatty acids are 
derived from endogenous triglyceride stores, through the action of  hormone sensitive 
lipase [122]. The stored TAG in BAT of  a newborn rabbit lasts only 30 hours under 
the infl uence of  thyroid hormones [123]. Maintenance of  BAT thermogenesis under 
prolonged periods requires provision of  fatty acids from other reserves of  the body as 
well as from the diet [120]. This requires the action of  lipoprotein lipase. This enzyme 
increases its activity during cold exposure, which presumably refl ects its increased 
synthesis within brown fat cells and secretion in the capillary lumen [124]. BAT has a 
considerably higher fatty acid releasing capacity than white fat [122].
In order to exhibit maximal thermogenesis during early postnatal life, BAT has to be 
fully mature at birth. It means that recruitment of  functional brown adypoticites must 
occur during fetal development. Detectable quantities of  perirenal adipose tissue fi rst 
appear in the ovine fetus at 70 days of  gestation, and then rapidly grow from 70 to 
120 days of  gestation [125]. Nevertheless, the development of  major morphological 
and biochemical features critical to functional BAT occurs until late gestation. This 
was confi rmed by detecting a signifi cant increase in bovine fetal UCP from perirenal 
adipose tissue depots starting from day 266 of  gestation [121]. BAT iodothyronine 5` 
deiodinase activity appeared in fetal perirenal tissue at 2 months of  gestation, achieved 
peak at 7 months of  gestation and subsequently decreased until birth [123]. It may be 
assumed that endogenous BAT conversion of  T4 to T3 may be involved in the prenatal 
induction of  UCP expression. 
At birth, BAT is located in the perirenal, inguinal and prescapular regions and amounts 
to about 2% of  body weight. Even though BAT accounts for only 2% of  body weight 
in newborn lambs, it can account for 40% of  maximal thermogenesis during cold 
exposure. During the fi rst month of  life BAT is rapidly converted to white adipose 
tissue leading to a decline in non-shivering thermogenesis in calves. The decline in non-
shivering thermogenesis coincides with rapid morphological changes in the BAT and 
the apparent conversion of  brown adipocytes to white adypocytes as demonstrated 
in calves [126]. Direct evidence for cellular conversion of  brown to white adipocytes 
remains to be demonstrated, although recent studies have shown that the postnatal 
disappearance of  morphologically identifi able BAT in neonatal ruminants is associated 
with a decrease in key biochemical characteristics of  BAT, including the decrease in 
the thermogenic activity of  brown adipocytes mitochondria [121], a reduction of  
expression of  UCP mRNA [127], and a decrease in the activity of  iodothyronine 
5`-deiodinase enzymes [128].  Cold- and diet-induced adaptation may slow or prevent 
this involution [129, 130]. 
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Shivering seems to be an important factor of  thermoregulation in new-born calves 
and it appears soon after birth in calves held at 10°C and stops when the hair coat is 
almost dry. When a new-born calf  struggles to get up, its heat production increases by 
30 to 100%. When the animal stands up for the fi rst time and spends 10 min standing, 
its energy expenditure is also increased by 100%. When it is a bit stronger and is able 
to stand for more than 30 min, heat production is increased by 40% on average over 
this period (personal results) [131]. 
During the suckling period, when the calf  is fed, colostrum constitutes are an excellent 
energy source (6.7 MJ/kg) for thermogenesis. In 24 Friesian calves held at 10 °C, heat 
production was increased on average by 18% and 9% respectively during the fi rst and 
the second hour following colostrum consumption at 12h of  age. An intake of  2 kg 
of  colostrum is able to meet the energy requirement of  a 40 kg new-born calf  held 
at 10 °C for 24h. Early consumption of  colostrum is therefore very important for 
thermoregulation [116, 132].
CONCLUSION
Endocrine and metabolic adaptations of  calves to extrauterine life are of  crucial 
importance for neonatal survival. The main hormones that contribute to these 
adaptations are those related to stress (cortisol and catecholamines), glucoregulatory 
processes (insulin and glucagon), themogenesis (thyroid hormones) and growth 
(IGF axis), while the main metabolic adaptations to extrauterine life are related to 
carbohydrates metabolism (since in utero and during postnatal starving period the 
ruminant is provided with high levels of  carbohydrates and low level of  fat) and 
thermogenesis (since the newborn is usually exposed to lower temperature compared 
to intra-uterine environment). An understanding of  maturation of  metabolic and 
endocrine mechanisms that are involved in the adaptations of  neonatal calves on 
extrauterine life, is essential for the implementation of  appropriate preventive measures 
that may contribute to increased survival of  neonatal calves.  
Acknowledgment 
The author is very grateful to Dr Martina Klinkon, professor at University of  Ljubljana 
Veterinary Faculty, Clinic for ruminants and ambulatory clinic, for critical reading of  
this work. 
Funding source: This work was supported by a project of  the Ministry of  Education, 
Science and Technological Development, Republic of  Serbia (No. III 46002). 
REFERENCES
1. Mee JF: Newborn dairy calf  management. Vet Clin North Am 2008, 24:1–17. 
Kirovski: Endocrine and metabolic adaptations of  calves to extra-uterine life
311
2. Silva del Río N, Stewart S, Rapnicki P, Chang YM, Fricke PM: An observational analysis 
of  twin births, calf  sex ratio, and calf  mortality in Holstein dairy cattle. J Dairy Sci 2007, 
90:1255–1264.
3. Uetake K: Newborn calf  welfare: a review focusing on mortality rates. Anim Sci J 2013, 
84(2):101-105.
4. Raboisson D, Delor F, Cahuzac E, Gendre C, Sans P, Allaire G: Perinatal, neonatal, 
and rearing period mortality of  dairy calves and replacement heifers in France. 
J Dairy Sci 2013, 96(5):2913-2924.
5. USDA, Heifer Calf  Health and Management Practices on U.S. Dairy Operations, 
USDA:APHIS:VS, CEAH. Fort Collins, CO; 2007.
6. MacFarlane JA, Grove-White DH, Royal MD, Smith RF: Identifi cation and quantifi cation 
of  factors affecting neonatal immunological transfer in dairy calves in the UK, Vet Rec 
2015, 176(24):625.
7. Cortese VS: Neonatal immunology. Vet Clin North Am Food Anim Pract 2009, 25(1):221-
227.
8. Chase CC, Hurley DJ, Reber AJ: Neonatal immune development in the calf  and its impact 
on vaccine response. Vet Clin North Am Food Anim Pract 2008, 24(1):87-104. 
9. Sangild PT: Uptake of  colostral immunoglobulins by the compromised newborn farm 
animal. Acta Vet Scand Suppl 2003, 98:105-122. 
10. Weaver DM, Tyler JW, VanMetre DC, Hostetler DE, Barrington GM: Passive transfer of  
colostral immunoglobulins in calves. J Vet Intern Med 2000, 14(6):569-577.
11. Hammon HM, Steinhoff-Wagner J, Schönhusen U, Metges CC, Blum JW: Energy 
metabolism in the newborn farm animal with emphasis on the calf: endocrine changes 
and responses to milk-born and systemic hormones. Domest Anim Endocrinol 2012, 
43(2):171-185. 
12. Blum JW, Hammon H: Endocrine and metabolic aspects in milk-fed calves. Domest Anim 
Endocrinol 1999, 17(2-3):219-230. 
13. Vannucchi CI, Rodrigues JA, Silva LC, Lúcio CF, Veiga GA, Furtado PV, Oliveira CA, Nichi 
M: Association between birth conditions and glucose and cortisol profi les of  periparturient 
dairy cows and neonatal calves. Vet Rec 2015, 176(14):358.
14. Chung HR: Adrenal and thyroid function in the fetus and preterm infant. Korean J 
Pediatr 2014, 57(10):425-433. 
15. Aurich JE, Dobrinski I, Petersen A, Grunert E, Rausch WD, Chan WW: Infl uence of  labor 
and neonatal hypoxia on sympathoadrenal activation and methionine enkephalin release in 
calves. Am J Vet Res 1993, 54(8):1333-1338.
16. Donkin SS, Armentano LE: Regulation of  gluconeogenesis by insulin and glucagon in 
the neonatal bovine. Am J Physiol 1994, 266:1229-1237.
17. Mullur R, Liu YY, Brent GA: Thyroid hormone regulation of  metabolism. Physiol 
Rev 2014, 94(2):355-382. 
18. Blum JW, Baumrucker CR: Insulin-like growth factors (IGFs), IGF binding proteins, and 
other endocrine factors in milk: role in the newborn. Adv Exp Med Biol 2008, 606:397-422. 
19. Yang K, Fraser M, Yu M, Krkosek M, Challis JR, Lamming GE, Campbell LE, Darnel 
A: Pattern of  11 beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid 
expression in the ovine uterus during the estrous cycle and pregnancy. Biol Reprod 1996, 
55(6):1231-1236.
Acta Veterinaria-Beograd 2015, 65 (3), 297-318
312
20. Pepe GJ, Burch MG, Albrecht ED: Localization and developmental regulation of  11 
beta-hydroxysteroid dehydrogenase-1 and -2 in the baboon syncytiotrophoblast. 
Endocrinology 2001, 142(1):68-80.
21. Steinhoff-Wagner J, Görs S, Junghans P, Bruckmaier RM, Kanitz E, Metges CC, Hammon 
HM: Maturation of  endogenous glucose production in preterm and term calves. J Dairy 
Sci 2011, 94(10):5111-5123. 
22. Plas C, Nunez J: Role of  cortisol on the glycogenolytic effect of  glucagon and on glycogenic 
response to insulin in fetal hepatocytes culture. J Biol Chem 1976, 251:1431-1437
23. Stojić V, Nikolić JA, Huszenicza Gy, Šamanc H, Gvozdić D, Kirovski D: Plasma levels of  
triiodothyronine, thyroxine and cortisol in newborn calves. Acta Veterinaria Beograd 2002, 
52:5-6. 
24. Grosvenor CE, Picciano MF, Baumrucker CR: Hormones and growth factors in milk. 
Endocr Rev 1993, 14(6):710-728.
25. Padbury JF, Ervin MG, Polk DH: Extrapulmonary effects of  antenatally administered 
steroids. J Pediatr 1996, 128:167–172. 
26. Sauter SN, Roffl er B, Philipona C, Morel C, Romé V, Guilloteau P, Blum JW, Hammon HM: 
Intestinal development in neonatal calves: effects of  glucocorticoids and dependence of  
colostrum feeding. Biol Neonate 2004, 85(2):94-104. 
27. Franko KL, Giussani DA, Forhead AJ, Fowden AL, Effects of  dexamethasone on the 
glucogenic capacity of  fetal, pregnant, and non-pregnant adult sheep. J Endocrinol 2007, 
192(1):67-73.
28. Girard JR, Caquet D, Guillet I: Control of  rat liver phosphorylase, glucose-6-phosphatase 
and phosphophenolphyruvate carboxykinase activities by insulin and glucagon during the 
perinatal period. Enzyme 1973,  15:272-285.
29. Gluckman PD, Sizonenko SV, Bassett NS: The transition from fetus to neonate: an 
endocrine perspective. Acta Paediatr Suppl 1999, 428:7-11.
30. Godfrey RW, Smith SD, Guthrie MJ, Stanko RL, Neuendorff  DA, Randel RD: Physiological 
responses of  newborn Bos indicus and Bos indicus x Bos taurus calves after exposure 
to cold. J Anim Sci 1991, 69(1):258-63.
31. Newnham JP, Marshall CL, Padbury JF, Lam RV, Hobel CJ, Fisher DA: Fetal catecholamine 
release with preterm delivery. Am J Obstet Gynecol 1984, 149:888-893. 
32. Cheung CY: Fetal adrenal medulla catecholamine response to hypoxia-direct and neural 
components. Am J Physiol 1990, 258:1340-1346.
33. Stein H, Oyama K, Martinez A, Chappel B, Padbury J: Plasma epinephrine appearance and 
clearance rates in fetal and newborn sheep. Am J Physiol 1993, 265:756-760. 
34. Richet E, Davicco MJ, Barlet JP: Plasma catecholamine concentrations in lambs and calves 
during the perinatal period. Reprod Nutr Dev 1985, 25:1007-1016.
35. Sperling MA, Ganguli S, Leslie N, Landt K: Fetal-perinatal catecholamine secretion: role in 
perinatal glucose homeostasis. Am J Physiol 1984, 247:69 -74.
36. Davidson D: Circulating vasoactive substances and hemodynamic adjustments at birth in 
lambs. J Appl Physiol 1987, 63:676-684. 
37. Himms-Hagen J: Brown adipose tissue thermogenesis: interdisciplinary studies. FASEB 
J 1990, 4(11):2890-2898.
38. Limesand SW, Rozance PJ, Smith D, Hay WW. Increased insulin sensitivity and maintenance 
of  glucose utilizationm rates in fetal sheep with placental insuffi ciency and intra-uterine 
growth restriction. Am J Physiol Endocrinol Metab 2007, 293:1716-1725.
Kirovski: Endocrine and metabolic adaptations of  calves to extra-uterine life
313
39. Gao F, Liu Y, Li L, Li M, Zhang C, Ao C, Hou X. Effects of  maternal undernutrition 
during late pregnancy on the development and function of  ovine fetal liver. Anim Reprod 
Sci 2014, 147(3-4):99-105.
40. Gadhia MM, Maliszewski AM, O’Meara MC, Thorn SR, Lavezzi JR, Limesand SW, Hay 
WW Jr, Brown LD, Rozance PJ: Increased amino acid supply potentiates glucose-stimulated 
insulin secretion but does not increase β-cell mass in fetal sheep. Am J Physiol Endocrinol 
Metab 2013, 304(4):352-362. 
41. Ford SP, Zhang L, Zhu M, Miller MM, Smith DT, Hess BW, Moss GE, Nathanielsz 
PW, Nijland MJ: Maternal obesity accelerates fetal pancreatic beta-cell but not alpha-cell 
development in sheep: prenatal consequences. Am J Physiol Regul Integr Comp Physiol 
2009, 297(3):835-843. 
42. Alexander DP, Assan R, Britton HG, Fenton E, Redstone D: Glucagon release in the sheep 
fetus. 1) Effect of  hypo- and hyperglycaemia and arginine. Biol Neonate 1976, 30:1-10. 
43. Kirovski D,  Lazarević M,  Baričević-Jones I,  Nedić O,  Masnikosa R, Nikolić JA: Effects of  
peroral insulin and glucose on circulating insulin-like growth factor-I, its binding proteins 
and thyroid hormones in neonatal calves. Can J Vet Res 2008, 72(3):253-258.
44. KawaiY, Arinze IJ: Activation of  Glycogenolysis in Neonatal Liver. J Biol Chem 1981, 256 
(2):853-858.
45. Donkin SS , Bertics  SJ, Armentano LE:  Chronic and transitional regulation of  
gluconeogenesis and glyconeogenesis by insulin and glucagon in neonatal calf  hepatocytes. 
J Anim Sci 1997, 75(11):3082-3087.
46. Charron MJ, Vuguin PM: Lack of  glucagon receptor signaling and its implications beyond 
glucose homeostasis. J Endocrinol 2015, 224(3):123-130.
47. Philippidis H, Ballard FJ: The development of  gluconeogenesis in rat liver. Effects of  
glucagon and ether. Biochem J 1970,  120(2):385-392.
48. Grütter R, Blum JW: Insulin and glucose in neonatal calves after peroral insulin and 
intravenous glucose administration. Reprod Nutr Dev 1991,31(4):389-397.
49. Prodanović R, Kirovski D, Vujanac I, Đurić M, Korićanac G, Vranješ-Đurić S, Ignjatović 
M, Šamanc H: Insulin responses to acute glucose infusions in Buša and Holstein-Friesian 
cattle breed during the peripartum period: comparative study. Acta Veterinaria Beograd 
2013, 63 (2-3): 373-384.
50. Fisher DA: Thyroid system immaturities in very low birth weight premature infants. Semin 
Perinatol 2008, 32:387-397. 
51. Breall JA, Rudolph AM, Heymann MA: Role of  thyroid hormone in postnatal circulatory 
and metabolic adjustments. J Clin Invest 1984, 73:1418-1424. 
52. Davicco MJ, Vigouroux E, Dardillat C, Barlet JP: Thyroxine, triiodothyronine and iodide in 
different breeds of  newborn calves. Reprod Nutr Dev 1982, 22(2):355-362.
53. Grongnet JF, Grongnet-Pinchon E, Witowski A: Neonatal levels of  plasma thyroxine in 
male and female calves fed a colostrum or immunoglobulin diet or fasted for the fi rst 28 
hours of  life. Reprod Nutr Dev 1985, 25(3):537-543.
54. Annunziata M, Granata R, Ghigo E: The IGF system. Acta Diabetol 2011, 48(1):1-9. 
55. Baxter RC: Insulin-like growth factor binding proteins in human circulation: a review. 
Horm Res 1994, 42:140-144.
56. Elhddad AS, Lashen H: Fetal growth in relation to maternal and fetal IGF-axes: a 
systematic review and meta-analysis. Acta Obstet Gynecol Scand 2013, 92(9):997-1006. 
Acta Veterinaria-Beograd 2015, 65 (3), 297-318
314
57. Mullis PE, Tonella P: Regulation of  fetal growth: consequences and impact of  being born 
small. Best Pract Res Clin Endocrinol Metab  2008, 22(1):173-190. 
58. Soos MA, Navé BT, Siddle K: Immunological studies of  type I IGF receptors 
and insulin receptors: characterisation of  hybrid and atypical receptor subtypes. Adv Exp 
Med Biol 1993, 343:145-157.
59. Owens JA: Endocrine and substrate control of  fetal growth: placental and maternal 
infl uences and insulin-like growth factors.  Reprod Fertil Dev 1991, 3(5):501-517.
60. Bang P, Westgren M, Schwander J, Blum WF, Rosenfeld RG, Stangenberg M: Ontogeny 
of  insulin-like growth factor-binding protein-1, -2, and -3: quantitative measurements by 
radioimmunoassay in human fetal serum. Pediatr Res 1994,  36(4):528-536.
61. Holt RI: Fetal programming of  the growth hormone-insulin-like growth factor axis.Trends 
Endocrinol Metab 2002, 13(9):392-397.
62. Hyatt MA, Walker DA, Stephenson T, Symonds ME: Ontogeny and nutritional manipulation 
of  the hepatic prolactin-growth hormone-insulin-like growthfactor axis in the ovine fetus 
and in neonate and juvenile sheep. Proc Nutr Soc 2004, 63(1):127-135.
63. Rajaram S, Baylink DJ, Mohan S: Insulin-like growth factor-binding proteins in serum and 
other biological fl uids: regulation and functions. Endocr Rev 1997,  18(6):801-831. 
64. Cordano P, Hammon HM, Morel C, Zurbriggen A, Blum JW: mRNA of  insulin-like growth 
factor (IGF) quantifi cation and presence of  IGF binding proteins, and receptors for growth 
hormone, IGF-I and insulin, determined by reverse transcribed polymerase chain reaction, 
in the liver of  growing and mature male cattle. Domest Anim Endocrinol 2000, 19(3):191-
208.
65. Sauter SN, Ontsouka E, Roffl er B, Zbinden Y, Philipona C, Pfaffl  M, Breier BH, Blum JW, 
Hammon HM: Effects of  dexamethasone and colostrum intake on the somatotropic axis 
in neonatal calves. Am J Physiol Endocrinol Metab 2003, 285(2):252-261.
66. Brameld JM, Gilmour RS, Buttery PJ: Glucose and amino acids interact with hormones to 
control expression of  insulin-like growth factor-I and growth hormone receptor mRNA in 
cultured pig hepatocytes. J Nutr 1999,129:1298 –1306.
67. McGuire MA, Dwyer DA, Harrell RJ, Bauman DE: Insulin regulates circulating insulin-like 
growth factors and some of  their binding proteins in lactating cows. Am J Physiol 1995, 
269:723–730.
68. Kirovski D, Lazarević M, Stojić V, Šamanc H, Vujanac I, Nedić O, Masnikosa R: Hormonal 
status and regulation of  glycemia in neonatal calves dutring the fi rst hours of  postnatal life. 
Acta Veterinaria Beograd 2011, 61(4): 349-361. 
69. Morovat A, Dauncey MJ: Effects of  thyroid status on insulin-like growth factor-I, growth 
hormone and insulin are modifi ed by food intake. Eur J Endocrinol 1998, 138(1):95-103.
70. Owens PC, Conlon MA, Campbell RG, Johnson RJ, King R, Ballard FJ: Developmental 
changes in growth hormone, insulin-like growth factors (IGF-I and IGF-II) and IGF-
binding proteins in plasma of  young growing pigs. J Endocrinol 1991, 128(3):439-447.
71. Baxter RC, Martin JL: Binding proteins for insulin-like growth factors in adult rat 
serum. Comparison with other human and rat binding proteins. Biochem Biophys Res 
Commun 1987, 147(1):408-415.
72. Binoux M: The IGF system in metabolism regulation. Diabete Metab 1995, 21(5):330-337. 
73. Murphy LJ: The role of  the insulin-like growth factors and their binding proteins in glucose 
homeostasis. Exp Diabesity Res 2003, 4(4):213-224. 
Kirovski: Endocrine and metabolic adaptations of  calves to extra-uterine life
315
74. Collett-Solberg PF, Cohen P: The role of  the insulin-like growth factor binding proteins and 
the IGFBP proteases in modulating IGF action: Endocrinol Metab Clin North Am 1996, 
25(3):591-614.
75. Bae JH, Song DK, Im SS: Regulation of  IGFBP-1 in Metabolic Diseases. J Lifestyle Med 
2013, 3(2):73-79. 
76. Skaar TC, Baumrucker CR, Deaver DR, Blum JW: Diet effects and ontogeny of  alterations 
of  circulating insulin-like growth factor binding proteins in newborn dairy calves. J Anim 
Sci 1994, 72(2):421-427.
77. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR: Hormonal and 
nutritional regulation of   IGF-I and its binding proteins. Horm Res 1994, 42(4-5):145-151.
78. Godden S: Colostrum management for dairy calves. Vet Clin North Am Food Anim 
Pract 2008, 24(1):19-39.
79. Stelwagen K, Carpenter E, Haigh B, Hodgkinson A, Wheeler TT: Immune components of  
bovine colostrums and milk. J Anim Sci 2009, 87 (13): 3-9.
80. Šamanc H, Sladojević Ž, Vujanac I, Prodanović R, Kirovski M, Dodovski P, Kirovski D: 
Relationship between growth of  nursing pigs and composition of  sow colostrum and milk 
from anterioar and posterior mammary glands. Acta veterinaria Beograd 2013, 63(5-6):537-
548.
81. Trajčev M, Nakov D, Hristov S, Andonov S, Joksimović-Todorović M: Clinical mastitis in 
Macedonian dairy herds. Acta veterinaria Beograd 2013, 63(1):63-76.
82. Maletić M, Vakanjac S, Djelić N, Lakić N, Pavlović M, Nedić S, Stanimirović Z: Analysis 
of  lactoferrin gene polymophism and its association to milk quality and mammary gland 
health in holstein-friesian cows. Acta veterinaria Beograd 2013, 63(5-6):487-498.
83. Kirovski D, Nikolić JA, Stojić V: Serum levels of  inuslin-like growth factor I and total 
protein in newborn calves offered different amounts of  colostrum. Acta Veterinaria 
Beograd 2002, 52(5-6): 285-298.
84. Hammon H, Blum JW: The somatotropic axis in neonatal calves can be modulated by 
nutrition, growth hormone, and Long-R3-IGF-I. Am J Physiol 1997,  273:130-138.
85. Vacher PY, Bestetti G, Blum JW: Insulin-like growth factor I absorption in the jejunum of  
neonatal calves. Biol Neonate 1995, 68(5):354-367.
86. Guilloteau P, Zabielski R, Blum JW: Gastrointestinal tract and digestion in the young 
ruminant: ontogenesis, adaptations, consequences and manipulations. J Physiol 
Pharmacol 2009, 60 (3):37-46.
87. Heinrichs C, Yanovski JA, Roth AH, Yu YM, Domené HM, Yano K, Cutler B Jr, Baron J: 
Dexamethasone increases growth hormone receptor messenger ribonucleic acid levels in 
liver and growth plate.  Endocrinology 1994,135: 1113-1118.
88. Baumrucker CR, Hadsell DL, Blum JW: Effects of  dietary insulin-like growth factor I on 
growth and insulin-like growth factor receptors in neonatal calf  intestine. J Anim Sci 1994, 
72(2):428-433.
89. Egli CP, Blum JW: Clinical, haematological, metabolic and endocrine traits during the fi rst 
three months of  life of  suckling simmentaler calves held in a cow-calf  operation. Zentralbl 
Veterinarmed A 1998, 45(2):99-118.
90. Livingstone C, Borai A: Insulin-like growth factor-II: its role in metabolic and endocrine 
disease. Clin Endocrinol (Oxf) 2014, 80(6):773-781. 
Acta Veterinaria-Beograd 2015, 65 (3), 297-318
316
91. McGowen JE, Aldoreta PW, Hay WW Jr: Contribution of  fructose and lactate produced 
in placenta to circulation of  fetal glucose oxidation rate. Am J Physiol 1995, 269 (5 Pt 1): 
E834-839. 
92. Hillman NH, Kallapur SG, Jobe AH: Physiology of  transition from intrauterine to 
extrauterine life. Clin Perinatol 2012, 39(4):769-783. 
93. Comline RS, Silver M: Some aspects of  foetal and uteroplacental metabolism in cows with 
indwelling umbilical and uterine vascular catheters. Physiol 1976, 260(3):571-586.
94. Gu W, Jones CT, Harding JE: Metabolism of  glucose by fetus and placenta of  sheep. The 
effects of  normal fl uctuations in uterine blood fl ow. J Dev Physiol 1987, 9(4):369-389.
95. Fowden AL, Mapstone J, Forhead AJ: Regulation of  glucogenesis by thyroid hormones 
in fetal sheep during late gestation. J Endocrinol 2001, 170(2):461-469.
96. Liang L, Guo WH, Esquiliano DR, Asai M, Rodriguez S, Giraud J, Kushner JA, White MF, 
Lopez MF: Insulin-like growth factor 2 and the insulin receptor, but not insulin, regulate 
fetal hepatic glycogensynthesis. Endocrinology 2010, 151(2):741-747.
97. Fowden AL, Forhead AJ: Adrenal glands are essential for activation of  glucogenesis during 
undernutrition in fetal sheep near term. Am J Physiol Endocrinol Metab 2011, 300(1):94-
102. 
98. Stratford LL, Hooper SB: Effect of  hypoxemia on tissue glycogen content and glycolytic 
enzyme activities in fetal sheep. Am J Physiol 1997, 272:103-110.
99. Fowden AL, Mijovic J, Ousey JC, McGladdery A, Silver M: The development 
of  gluconeogenic enzymes in the liver and kidney of  fetal and newborn foals. J Dev Physiol 
1992, 18(3):137-142.
100. Houin SS, Rozance PJ, Brown LD, Hay WW Jr, Wilkening RB, Thorn SR: Coordinated 
changes in hepatic amino acid metabolism and endocrine signals support hepatic glucose 
production during fetal hypoglycemia. Am J Physiol Endocrinol Metab 2015, 308(4):306-
314.
101. Scheuer BH, Zbinden Y, Schneiter P, Tappy L, Blum JW, Hammon HM: Effects of  
colostrum feeding and glucocorticoid administration on insulin-dependent glucose 
metabolism in neonatal calves. Domest Anim Endocrinol 2006, 31(3):227-245. 
102. Edwards AV, Silver M: The glycogenolytic response to stimulation of  the splanchnic 
nerves in adrenalectomized calves. J Physiol 1970, 211(1):109-124.
103. Power GG, Yoneyama Y, Asakura H, Sawa R: Disappearance of  palmitic acid from plasma 
of  fetal and newborn sheep. J Appl Physiol 1993, 74(1):62-67.
104. Hammon HM, Steinhoff-Wagner J, Flor J, Schönhusen U, Metges CC: Lactation Biology 
Symposium: role of  colostrum and colostrum components on glucose metabolism in 
neonatal calves. J Anim Sci 2013, 91(2):685-695. 
105. Hammon HM, Philipona C, Zbinden Y, Blum JW, Donkin SS: Effects of  dexamethasone 
and growth hormone treatment on hepatic gluconeogenic enzymes in calves. J Dairy Sci 
2005, 88(6):2107-2116.
106. Keller HL, Gherman LI, Kosa RE, Borger DC, Weiss WP, Willett LB: Kinetics of  
plasma fructose and glucose when lactose and fructose are used as energy supplements 
for neonatal calves. J Anim Sci 1998, 76(8):2197-204.
107. Steinhoff-Wagner J, Görs S, Junghans P, Bruckmaier RM, Kanitz E, Metges CC, Hammon 
HM: Intestinal glucose absorption but not endogenous glucose production differs between 
colostrum- and formula-fed neonatal calves. J Nutr  2011, 141(1):48-55. 
Kirovski: Endocrine and metabolic adaptations of  calves to extra-uterine life
317
108. Hammon HM, Sauter SN, Reist M, Zbinden Y, Philipona C, Morel C, Blum JW: 
Dexamethasone and colostrum feeding affect hepatic gluconeogenic enzymes differently 
in neonatal calves. J Anim Sci 2003, 81(12):3095-3106.
109. Lepine AJ, Boyd RD, Whiteheat DM: Effect of  colostrum intake on hepatic gluconeogenesis 
and fatty acid oxidation in neonatal pig. J Anim Sci 1991, 69 (5): 1966-1974. 
110. Rauprich AB, Hammon HM, Blum JW: Effects of  feeding colostrum and a formula with 
nutrient contents as colostrum on metabolic and endocrine traits in neonatal calves. Biol 
Neonate 2000, 78(1):53-64.
111. Schäff  CT, Rohrbeck D, Steinhoff-Wagner J, Kanitz E, Sauerwein H, Bruckmaier 
RM, Hammon HM: Effects of  colostrum versus formula feeding on hepatic glucocorticoid 
and α1- and β2-adrenergic receptors inneonatal calves and their effect on glucose and lipid 
metabolism. J Dairy Sci 2014, 97(10):6344-6357. 
112. Hocquette JF, Bauchart D: Intestinal absorption, blood transport and hepatic and muscle 
metabolism of  fatty acids in preruminant and ruminant animals. Reprod Nutr Dev 1999, 
39(1):27-48.
113. Smith SB, Crouse JD: Relative contributions of  acetate, lactate and glucose to lipogenesis 
in bovine intramuscular and subcutaneous adipose tissue. J Nutr 1984, 114(4):792-800. 
114. Lammoglia MA, Bellows RA, Short RE, Bellows SE, Bighorn EG, Stevenson JS, Randel 
RD: Body temperature and endocrine interactions before and after calving in beef  cows. J 
Anim Sci 1997, 75(9):2526-2534.
115. Carstens GE: Cold thermoregulation in the newborn calf. Vet Clin North Am Food  Anim 
Pract 1994, 10(1):69-106.
116. Robinson JB, Young BA: Metabolic heat production of  neonatal calves during hypothermia 
and recovery. J Anim Sci 1988, 66(10):2538-44.
117. Labussière E, van Milgen J, de Lange CF, Noblet J: Maintenance energy requirements of  
growing pigs and calves are infl uenced by feeding level. J Nutr  2011, 141(10):1855-1861. 
118. Zanker IA, Hammon HM, Blum JW: Delayed feeding of  fi rst colostrum: are there 
prolonged effects on haematological, metabolic and endocrine parameters and on growth 
performance in calves?. J Anim Physiol Anim Nutr (Berl)  2001, 85(3-4):53-66.
119. Koldovský O, Dobiásová M, Drahota Z, Hahn P: Developmental aspects of  lipid 
metabolism. Physiol Res 1995, 44(6):353-356.
120. Smith SB, Carstens GE, Randel RD, Mersmann HJ, Lunt DK: Brown adipose 
tissue development and metabolism in ruminants. J Anim Sci 2004, 82(3):942-954.
121. Casteilla L, Forest C, Robelin J, Ricquier D, Lombet A, Ailhaud G: Characterization of  
mitochondrial-uncoupling protein in bovine fetus and newborn calf. Am J Physiol 1987, 
252:627-636.
122. Himms-Hagen J, Cui J, Lynn Sigurdson S: Sympathetic and sensory nerves in control of  
growth of  brown adipose tissue: Effects of  denervation and of  capsaicin. Neurochem 
Int 1990,17(2):271-279.
123. Giralt M, Casteilla L, Viñas O, Mampel T, Iglesias R, Robelin J, Villarroya F: Iodothyronine 
5’-deiodinase activity as an early event of  prenatal brown-fat differentiation in bovine 
development. Biochem J 1989, 259(2):555-559.
124. Khedoe PP, Hoeke G, Kooijman S, Dijk W, Buijs JT, Kersten S, Havekes LM, Hiemstra 
PS, Berbée JF, Boon MR, Rensen PC: Brown adipose tissue takes up plasma triglycerides 
mostly after lipolysis. J Lipid Res 2015, 56(1):51-59. 
Acta Veterinaria-Beograd 2015, 65 (3), 297-318
318
125. Alexander G: Quantitive development of  adipose tissue in fetal sheep. Aust J Biol Sci 
1978, 31: 489-503.
126. Alexander G: Body temperature control in mammalian young. Br Med Bull 1975, 31(1):62-
8.
127. Trayhurn P, Thomas ME, Keith JS: Postnatal development of  uncoupling protein, 
uncoupling protein mRNA, and GLUT4 in adipose tissues of  goats. Am J Physiol 1993, 
265:676-682.
128. Trayhurn P, Thomas ME, Duncan JS, Nicol F, Arthur JR: Presence of  the brown fat-
specifi c mitochondrial uncoupling protein and iodothyronine 5’-deiodinase activity in 
subcutaneous adipose tissue of  neonatal lambs. FEBS Lett 1993, 322(1):76-78.
129. Holloway BR, Davidson RG, Freeman S, Wheeler H, Stribling D: Post-natal development 
of  interscapular (brown) adipose tissue in the guinea pig: effect of  environmental 
temperature. Int J Obes 1984, 8(4):295-303.
130. Restelli L, Lecchi C, Invernizzi G, Avallone G, Savoini G, Ceciliani F: UCP1 and UCP2 
expression in different subcutaneous and visceral adipose tissue deposits in 30 days old 
goat kids and effect of  fatty acid enriched diets. Res Vet Sci 2015, 100:131-137. 
131. Vermorel M, Dardillat C, Vernet J, Saido, Demigne C: Energy metabolism and 
thermoregulation in the newborn calf. Ann Rech Vet 1983,14(4):382-389.
132. Herpin P, Le Dividich J, Van Os M: Contribution of  colostral fat to thermogenesis and 
glucose homeostasis in the newborn pig. J Dev Physiol 1992, 17(3):133-141.
HORMONSKA I METABOLIČKA ADAPTACIJA TELADI NA 
EKSTRAUTERINE USLOVE ŽIVOTA 
KIROVSKI Danijela
Prelaz iz intrauterinog u ekstrauterini period života je jedan od najvećih fi zioloških iza-
zova koji se dešavaju tokom života životinje. Odmah nakon rođenja, novorođena telad 
treba da se prilagode novim uslovima ambijenta i ishrane. Naime, prilikom rođenja 
dolazi do prekida temperaturnog balansa organizma, pošto tele naglo prelazi iz in-
trauterine sredine, gde vlada temperatura od 38,8 °C, u ekstaruterinu sredinu gde je 
spoljašnja temperature obično niža od 20 °C. Dodatno, tada se snabdevanje energijom 
menja jer od kontinuiranog parenteralnog snabdevanja (pretežno glukozom) prelazi na 
diskontinuirano, koje se ostvaruje unošenjem kolostruma i mleka u kojima su glavni 
izvor energije laktoza i masti. Zbog toga su najznačajnije promene tokom prelaska 
iz intrauterinog u ekstrauterini život  vezane za održavanje stalne telesne temperatu-
re i kontrolu energetskog metabolizama. Te promene su pod kontrolom endokrinog 
sistema koji je relativno razvijen u momentu rođenja ali ipak zahteva dodatne mor-
fološke i funkcionalne promene posle rođenja. Ključni hormoni čija se koncentracija 
značajno menja u periodu oko rođenja i koji su uključeni u adekvatnu adaptaciju teladi 
na ekstrauterine uslove života su oni koje su povezani sa stresom na rođenju (kortizol 
i kateholamini), procesima regulacije glikemije (insulin i glukagon), termogenezom (ti-
reoidni hormoni) i rastom (IGF osovina). 
